Cabanillas M, Dadu R, Iyer PC, Wanland KB, et al. Acquired secondary RAS mutation in BRAFV600E mutated thyroid cancer patients treated with BRAF inhibitors. Thyroid 2020 Mar 26. doi: 10.1089/thy.2019.0514.
PMID: 32216548